Abstract
Posaconazole is a new antifungal agent, which exhibits a broad spectrum of activity against fungi including Aspergillus terreus, some zygomycetes and dematiaceous fungi. Out of the group of triazole antifungal agents, it is the only compound for which interpretive breakpoints have not been established have not yet been established for Candida spp. As reliable breakpoints are useful in the practical management of patients with fungal infections, it is desirable to establish the same for all available substances. However, the underlying data of the existing breakpoints for other antifungal agents are of varying quality because of limited clinical data available. Furthermore, these breakpoints are not equally suitable for all testing methods available and they may not be suitable for all species to be tested. From the practical point of view, it is therefore important not only to establish breakpoints for the reference method but also for the inexpensive and easy to perform testing methods, which are suitable for smaller laboratories.
References
Jun 1, 1997·Antimicrobial Agents and Chemotherapy·D W DenningS L Kelly
Oct 24, 1997·The Journal of Antimicrobial Chemotherapy·D W DenningD W Warnock
Nov 18, 1998·The Journal of Antimicrobial Chemotherapy·C Lass-FlörlD Niederwieser
Nov 5, 1999·Mycoses·R FranzJ Morschhäuser
Aug 23, 2001·International Journal of Antimicrobial Agents·K UchidaH Yamaguchi
Sep 15, 2001·Antimicrobial Agents and Chemotherapy·M A PfallerR N Jones
Mar 19, 2002·Antimicrobial Agents and Chemotherapy·M A PfallerUNKNOWN SENTRY Participants Group
Aug 1, 2002·Journal of Clinical Microbiology·G MoraceL Pitzurra
Oct 2, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John H Rex, Michael A Pfaller
Mar 8, 2003·Journal of Clinical Microbiology·M J MaxwellM A Pfaller
Aug 6, 2005·Journal of Clinical Microbiology·A Espinel-IngroffP E Verweij
Oct 7, 2005·Journal of Clinical Microbiology·M A PfallerD J Diekema
Mar 3, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jo-Anne H van BurikDimitrios P Kontoyiannis
Mar 7, 2006·Journal of Clinical Microbiology·M A PfallerD W Warnock
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·Benjamin J ParkDavid W Warnock
May 26, 2006·Antimicrobial Agents and Chemotherapy·F SabatelliP M McNicholas
Jun 8, 2006·Journal of Clinical Microbiology·Charles R SimsLuis Ostrosky-Zeichner
Sep 12, 2006·Mycoses·H Hof
Jan 26, 2007·The New England Journal of Medicine·Oliver A CornelyDavid Angulo-Gonzalez
Feb 3, 2007·Journal of Clinical Microbiology·Shawn A MesserMichael A Pfaller
Feb 13, 2007·The Journal of Antimicrobial Chemotherapy·Ralf FleckHerbert Hof
Feb 16, 2007·Journal of Clinical Microbiology·Daniel J DiekemaMichael A Pfaller
May 23, 2007·Expert Opinion on Pharmacotherapy·Douglas S Kwon, Eleftherios Mylonakis
Jun 20, 2007·Antimicrobial Agents and Chemotherapy·Olivier LortholaryUNKNOWN YEASTS Group
Citations
Oct 22, 2009·Natural Product Research·Berenice Aguilar-GuadarramaMaría Yolanda Rios
Jan 11, 2012·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Nlandu R NgatuNarufumi Suganuma
Nov 26, 2009·Drugs·Antonino Gullo
Feb 1, 2010·Journal of Pharmacy Practice·Elizabeth A Coyle
Oct 15, 2009·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Claus SeebacherHans-Jürgen Tietz
Jul 1, 2016·Current Fungal Infection Reports·Bart G J DekkersJan-Willem C Alffenaar
May 17, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Maximiliano SortinoSusana Zacchino
Oct 16, 2013·Mycoses·M SakkoR Rautemaa
Jun 1, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Patrícia L A NascimentoTania M S Silva